Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorTaumedika s.r.l.

About this trial

Study to validate the safety and efficacy of the Hyaluronic Acid +Collagen filler 40 patients will undergo through 3 visits one to asses the health and apply the filler one after 4 weeks to check the results one after 16 weeks for the final check and results validation Safety assessed with analysis of the Adverse Events

Eligibility criteria

Qualifiers

all sexes

caucasic

18 to 70 years

non smoker

Disqualifiers

Pregnancy

milking

smoker

alcohol or drugs abuse

Trial design

Treatments tested in this trial

  • Karisma

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Taumedika s.r.l.

Lead sponsor

Nextrasearch S.r.l.s.

Collaborator